Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
4Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Biofrontera Inc. (BFRI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
1Distinct source URLs
6High confidence
0.785Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Biofrontera Inc. Suppliers
Ticker
Name
Confidence
Evidence
MIDAS-PHARMA-GMBH
MIDAS-PHARMA-GMBH
92%
Among other things, the Supply Agreement provides that Midas will supply Discovery or its contract manufacturers, in the aggregate, 100 kg of the active pharmaceutical ingredient ("API") 5-Aminolevul…
BIOFRONTERA-PHARMA-GMBH
BIOFRONTERA-PHARMA-GMBH
85%
Pursuant to the Second A&R Ameluz LSA, the price paid was set at twenty-five percent of the anticipated net selling price per unit through 2025 (the "Transfer Price") that covered the cost of goods,
Biofrontera Inc. Customers
Ticker
Name
Confidence
Evidence
BIOFRONTERA-AG
BIOFRONTERA-AG
62%
ult at March 31, 2026. The Notes are secured by substantially all property of the Company, including but not limited to the Company’s assets, inventory, intellectual property and accounts. The Notes …
BIOFRONTERA-GROUP
BIOFRONTERA-GROUP
62%
ult at March 31, 2026. The Notes are secured by substantially all property of the Company, including but not limited to the Company’s assets, inventory, intellectual property and accounts. The Notes …
BIOFRONTERA-PHARMA-GMBH
BIOFRONTERA-PHARMA-GMBH
62%
ult at March 31, 2026. The Notes are secured by substantially all property of the Company, including but not limited to the Company’s assets, inventory, intellectual property and accounts. The Notes …
PREFERRED-STOCK-BIOFRONTERA-AG
PREFERRED-STOCK-BIOFRONTERA-AG
62%
ult at March 31, 2026. The Notes are secured by substantially all property of the Company, including but not limited to the Company’s assets, inventory, intellectual property and accounts. The Notes …
Biofrontera Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BFRI-DEBT-8162
Warrants outstanding: 100
90%
xbrl warrant detail from xbrl 2025-12-31.
BFRI-DEBT-8163
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
BFRI-DEBT
Debt stack $7.7M
90%
Market cache reports total debt of $7.7M.
Biofrontera Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Biofrontera Inc..
Biofrontera Inc. Ownership
Holder
Name
Confidence
Evidence
BFRI-OWNER-ROSALIND-ADVISORS-INC
Rosalind Advisors, Inc.
90%
13F overlay lists Rosalind Advisors, Inc. as top holder; 12 tracked holders.
Biofrontera Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
